Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation

Internal Medicine Journal

Volumn 41, Issue 4, 2011, Pages 337-343

  Tran, H ^a,b   Collecutt, M ^a   Whitehead, S ^a   Salem, H H ^b,c  

^a Alfred Pathology Service   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Anticoagulation; Bleeding; Prothrombin complex concentrate; Warfarin reversal

Indexed keywords

PROTHROMBIN COMPLEX; PROTHROMBINEX VF; UNCLASSIFIED DRUG; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FATALITY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; PATIENT SAFETY; PRIORITY JOURNAL; THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; COHORT STUDIES; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; WARFARIN;

EID: 79954985885     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02237.x     Document Type: Article

References (21)

1. Bereznicki L. Unit for Medication Outcomes Research and Education (UMORE): Tasmanian School of Pharmacy, University of Tasmania. Media Release 10 November 2008.
2. Bajorek BV, Yau L, Lee K, Zulueta W. Management of over anticoagulation in warfarinised hospital patients. J Pharm Pract Res 2009; 39: 13-18.
3. Hylek EM, Regan S, Go AS, Hughes RA, Singe DE, Skates SJ. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med 2001; 135: 393-400.
4. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A etal. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348: 423-8.
5. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998; 105: 91-9.
6. Humphries JE, Ortel TL. Treatment of acquired disorders of hemostasis. In: Mintz PD, ed. Transfusion Therapy: Clinical Principles and Practice. Bethesda, MD: American Association of Blood Banks; 2005; 91-120.
7. Schulman S, Bijsterveld NR. Anticoagulants and their reversal. Transfus Med Rev 2007; 21: 37-48.
8. PROTHROMBINEX-VF Approved Product Information. Date of most recent amendment: 11 February 2009.
9. Baker R, Coughlin P, Gallus A, Harper P, Salem H, Wood E. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 2004; 181: 492-7.
10. Hatem JS, Poulton L. Warfarin anticoagulation can be effectively reversed with Prothrombinex®-VF without the need for fresh frozen plasma. Abstract 053 HAA 2008 Perth.
11. Chiu D, Grigg M, Levi E. Operating on patients with warfarin: simpler alternative approach. ANZ J Surg 2009; 79: 409-10.
12. Crawford JH, Auguston BM. Prothrombinex use for the reversal of warfarin: is fresh frozen plasma needed? Med J Aust 2006; 184: 365-6.
13. Imberti D, Barillari G, Biasioli C, Bianchi M, Contini L, Duce R etal. Prothrombin complex concentrates for urgent anticoagulation reversal in patients with intracranial haemorrhage. Pathophysiol Haemost Thromb 2008; 36: 259-65.
14. Holland L, Warkentin TE, Refaai M, Crowther MA, Johnston MA, Sarode R. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supra-therapeutic international normalized ratio due to warfarin overdose. Transfusion 2009; 49: 1171-7.
15. Yasaka M, Sakata T, Naritomi H, Minematsu K. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Thromb Res 2005; 15: 455-9.
16. Lankiewicz MW, Hays J, Friedman KD, Tinkoff G, Blatt PM. Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost 2006; 4: 967-70.
17. Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H. Beriplex P/N Anticoagulation Reversal Study Group: prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost 2008; 6: 622-31.
18. Fredriksson K, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 1992; 23: 972-7.
19. Makris M, Graves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF. Emergency oral anticogulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997; 7: 477-80.
20. Boulis NM, Bobek MP, Schmaier A, Hoff JT. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 1999; 45: 1113-19.
21. Cartmill M, Dolan G, Byrne JL, Byrne PO. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergency. Br J Neurosurg 2000; 14: 458-61.